Correction to: A tumor-selective adenoviral vector platform induces transient antiphospholipid antibodies, without increased risk of thrombosis, in phase 1 clinical studies
-
Published:2023-05-11
Issue:3
Volume:41
Page:539-539
-
ISSN:0167-6997
-
Container-title:Investigational New Drugs
-
language:en
-
Short-container-title:Invest New Drugs
Author:
Khalil Danny N.,González-Albo Isabel Prieto,Rosen Lee,Lillie Tom,Stacey Andrea,Parfitt Lola,Soff Gerald A.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Oncology